The safety of proton pump inhibitors in pregnancy

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 8, 1999, Pages 1085-1089

  Nielsen, G L ^a,b,e   SOrensen H T ^a,b,c   Thulstrup, A M ^b,c   Tage Jensen, U ^a   Olesen, C ^b   Ekbom, A ^d  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF AARHUS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CONCEPTION; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DATA BASE; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; PHARMACOEPIDEMIOLOGY; PREGNANCY; PREMATURITY; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ADULT; DATABASES; DENMARK; ENZYME INHIBITORS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRESCRIPTIONS, DRUG; PROTON PUMPS; REGRESSION ANALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0032853469     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00578.x     Document Type: Article

References (12)

1. 1 Sørensen HT, Nielsen GL, Andersen AMN, Zhou W, Steffensen FH, Olsen J. Drug use in pregnancy: principal problems and a review of newer utilisation studies. Clin Res Regul Affairs 1996; 13: 181-97.
2. 2 Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Baltimore: Williams & Wilkins 1994: 642.
3. 3 Ching MS, Morgan DJ, Mikaly GW, Hardy KF, Smallwood RA. Placental transfer of omeprazole in maternal and fetal sheep. Dev Pharmacol Ther 1986; 9: 323-31.
4. 4 Lalkin A, Magee L, Addis A, Loebstein R, Koren G. Acid-suppressing drugs during pregnancy. Can Fam Physician 1997; 43: 1923-4.
5. 5 Källén B, Delivery outcome after use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol 1998; 105: 877-81.
6. 6 Lalkin A, Lobstein R, Addis A, et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 1998; 179: 727-30.
7. 7 Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997; 44: 445-8.
8. 8 Nielsen GL, Soørensen HT, Zhou W, Steffensen FH, Olsen J, The Pharmaco-Epidemiologic Prescription Database of North Jutland. Int J Risk Safety Med 1997; 10: 203-5.
9. 9 Sundhedsstyrelsen. Aktiviteten i sygehusvaesenet 1979. Copenhagen, Denmark: Sygehusstatistik, 1981.
10. 10 Nielsen GL, Sørensen HT, Nielsen PH, Sabroe S, Olsen J, Glycosylated haemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies. Acta Diabetologica 1997; 34: 217-22.
11. 11 Jick SS, Terris BZ. Anticonvulsants and congenital malformations. Pharmacotherapy 1997; 17: 561-4.
12. 12 Czeizel AE, Intody Z, Modell B. What proportion of congenital abnormalities can be prevented? Br Med J 1993; 306: 499-503.